Author:
Dobrovolsky A. B.,Laguta P. S.,Guskova E. V.,Yarovaya E. B.,Titaeva E. V.,Storozhilova A. N.,Panchenko E. P.
Subject
Biochemistry,General Medicine
Reference20 articles.
1. Sanz, J., Moreno, P. R., and Fuster, V. (2013) The year in atherothrombosis, J. Am. Coll. Cardiol., 62, 1131–1143.
2. Cattaneo, M. (2012) Response variability to clopidogrel: is tailored treatment, based on laboratory testing, the right solution? J. Thromb. Haemost., 10, 327–336.
3. Aradi, D., Kirtane, A., Bonello, L., Gurbel, P. A., Tantry, U. S., Huber, K., Freynhofer, M. K., Ten Berg, J., Janssen, P., Angiolillo, D. J., Siller-Matula, J. M., Marcucci, R., Patti, G., Mangiacapra, F., Valgimigli, M., Morel, O., Palmerini, T., Price, M. J., Cuisset, T., Kastrati, A., Stone, G. W., and Sibbing, D. (2015) Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention, Eur. Heart J., 36, 1762–1771.
4. Malinin, A., Pokov, A., Spergling, M., Defranco, A., Schwartz, K., Schwartz, D., Mahmud, E., Atar, D., and Serebruany, V. (2007) Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12 rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study, Thromb. Res., 119, 277–284.
5. Fibrinogen Studies Collaboration (2005) Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis, JAMA, 294, 1799–1809.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献